| pubmed-article:21288774 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0376705 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0033607 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C1373120 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
| pubmed-article:21288774 | lifeskim:mentions | umls-concept:C1707719 | lld:lifeskim |
| pubmed-article:21288774 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21288774 | pubmed:dateCreated | 2011-4-1 | lld:pubmed |
| pubmed-article:21288774 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:abstractText | Children with HIV will be on antiretroviral therapy (ART) longer than adults, and therefore the durability of first-line ART and timing of switch to second-line are key questions. We assess the long-term outcome of protease inhibitor and non-nucleoside reverse transcriptase inhibitor (NNRTI) first-line ART and viral load switch criteria in children. | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21288774 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21288774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21288774 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21288774 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21288774 | pubmed:issn | 1474-4457 | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:HughesMichael... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:MofensonLynne... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:FiscusSusanS | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:GiaquintoCarl... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:BabikerAbdelA | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:GibbDiana MDM | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:WalkerA... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:SaidiYacineY | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:McKinneyRossR | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:CompagnucciAl... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:HarperLyndaL | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:Tudor-William... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:HarrisonLinda... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:SmithM... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:MelvinAnnA | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:PENPACT-1... | lld:pubmed |
| pubmed-article:21288774 | pubmed:author | pubmed-author:Castro nee... | lld:pubmed |
| pubmed-article:21288774 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21288774 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21288774 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:21288774 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21288774 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21288774 | pubmed:pagination | 273-83 | lld:pubmed |
| pubmed-article:21288774 | pubmed:dateRevised | 2011-6-10 | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:meshHeading | pubmed-meshheading:21288774... | lld:pubmed |
| pubmed-article:21288774 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21288774 | pubmed:articleTitle | First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. | lld:pubmed |
| pubmed-article:21288774 | pubmed:affiliation | MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK. lijh@ctu.mrc.ac.uk | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:21288774 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21288774 | lld:pubmed |
